<DOC>
	<DOCNO>NCT01276288</DOCNO>
	<brief_summary>The primary objective study investigate effect BI 10773 , hydrochlorothiazide torasemide change serum urine electrolyte . Furthermore pharmacodynamic pharmacokinetic interaction BI 10773 diuretic assess .</brief_summary>
	<brief_title>Pharmacodynamics Pharmacokinetics Empagliflozin Torasemide Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Empagliflozin</mesh_term>
	<mesh_term>Torsemide</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Inclusion criterion : 1. male female patient type 2 diabetes</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>